AI assistant
Applied Therapeutics, Inc. — Director's Dealing 2022
May 19, 2022
34263_dirs_2022-05-18_f718b3fa-d24a-4c81-9834-c49e0e768b4d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Applied Therapeutics Inc. (APLT)
CIK: 0001697532
Period of Report: 2022-05-16
Reporting Person: Mahadevan Chids (See Remarks)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-05-16 | Common Stock | S | 905 | $1.65 | Disposed | 9800 | Direct |
Footnotes
F1: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
F2: Weighted average price. These shares were sold in multiple transactions at prices ranging from $1.6500 to $1.7000 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.